In vitro tests for the diagnosis of aspirin-sensitive asthma

Citations of this article
Mendeley users who have this article in their library.


In patients with aspirin-sensitive asthma, no significant changes in plasma β-thromboglobulin or bicyclic prostaglandin (PG) E2 were observed during aspirin challenge. The addition of aspirin to platelet suspensions from patients with aspirin-sensitive asthma produced no detectable chemiluminescence. Small concentrations of aspirin generated PGF2α but not PGE2 or PGD2 from plasma in vitro. PGF2α levels were significantly higher in plasma from aspirin-sensitive patients and distinguished aspirin-sensitive from aspirin-tolerant patients with asthma. The results of this study suggest that the displacement of protein-bound PGF2α may be of importance in the pathogenesis of aspirin-induced asthma. © 1990 Mosby-Year Book, Inc.




Williams, W. R., Pawlowicz, A., & Davies, B. H. (1990). In vitro tests for the diagnosis of aspirin-sensitive asthma. The Journal of Allergy and Clinical Immunology, 86(4 PART 1), 445–451.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free